STOCK TITAN

Traws Pharma (NASDAQ: TRAW) group holds 6.4% (511,714 shares)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Traws Pharma discloses a 6.4% stake held by Squadron Master Fund LP and affiliated filers. The Schedule 13G/A (Amendment No. 3) reports that Squadron Master Fund LP, Squadron Capital Management LLC, Matthew Sesterhenn and William Blank each have shared voting and dispositive power over 511,714 shares.

The filing bases the ownership percentage on 7,990,867 shares outstanding as of November 10, 2025, per the issuer's Form 10-Q. Signatures on the amendment are dated 05/15/2026.

Positive

  • None.

Negative

  • None.

Insights

Large passive stake disclosed by an investment fund and affiliated advisers.

The filing shows a 511,714-share holding reported for Squadron Master Fund LP and related parties, representing 6.4% of the class based on November 10, 2025 outstanding shares. The position is reported with shared voting and dispositive power.

Because the filing is a Schedule 13G/A amendment and the advisers disclaim beneficial ownership under Rule 13d-4, this appears to be an ownership disclosure rather than an intent to control; subsequent filings would show any change in voting stance.

Form categorization and disclaimers are explicit; no admission of beneficial ownership.

The statement notes Squadron Capital Management LLC is an Exempt Reporting Adviser and includes the Rule 13d-4 disclaimer that the advisers and named partners "expressly disclaim beneficial ownership." This language affects attribution of voting intent.

Filers identify shared dispositive power and provide the issuer-reported outstanding share count as of November 10, 2025, which anchors the disclosed 6.4% ownership.

Shares held 511,714 shares Reported holding by Squadron Master Fund LP and affiliates
Percent of class 6.4% Calculated using outstanding shares as of November 10, 2025
Shares outstanding 7,990,867 shares Outstanding as of November 10, 2025 per issuer Form 10-Q
Amendment signature date 05/15/2026 Date signatures appear on the Schedule 13G/A amendment
Schedule 13G/A regulatory
"The Schedule 13G/A (Amendment No. 3) reports that Squadron Master Fund LP"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
shared dispositive power financial
"Shared Dispositive Power 511,714.00 is reported for the filers"
Exempt Reporting Adviser regulatory
"Squadron Capital Management, LLC is an investment adviser that is registered as an Exempt Reporting Adviser"
Rule 13d-4 disclaimer regulatory
"Pursuant to Rule 13d-4, Squadron Capital Management, LLC and Mr. Sesterhenn and Mr. Blank expressly disclaim beneficial ownership"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





68232V884

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Squadron Master Fund LP
Signature:/s/ Matthew Sesterhenn
Name/Title:Partner, Squadron Partners LLC, its General Partner
Date:05/15/2026
Squadron Capital Management LLC
Signature:/s/ Matthew Sesterhenn
Name/Title:Partner
Date:05/15/2026
Matthew Sesterhenn
Signature:/s/ Matthew Sesterhenn
Name/Title:Matthew Sesterhenn
Date:05/15/2026
William Blank
Signature:/s/ William Blank
Name/Title:William Blank
Date:05/15/2026

FAQ

What stake does Squadron Master Fund LP report in TRAW?

The filing reports 511,714 shares held by Squadron Master Fund LP, equal to 6.4% of common stock based on 7,990,867 shares outstanding as of November 10, 2025 as represented in the issuer's Form 10-Q.

Who else is named on the Schedule 13G/A alongside Squadron Master Fund LP?

The amendment lists Squadron Capital Management LLC, and individuals Matthew Sesterhenn and William Blank, each reported with shared voting and shared dispositive power over 511,714 shares and the same 6.4% percentage.

Does the filing claim that the advisers beneficially own the shares?

No; the statement includes a disclaimer under Rule 13d-4 where Squadron Capital Management LLC and Messrs. Sesterhenn and Blank "expressly disclaim beneficial ownership" of the reported securities despite being shown with shared powers.

What outstanding share count does the filing use to calculate the percentage?

The ownership percentages are calculated using 7,990,867 shares outstanding, which the filing says is the issuer-represented total as of November 10, 2025 in the company's Form 10-Q filed November 14, 2025.

When was the Schedule 13G/A amendment signed?

The amendment shows signatures dated 05/15/2026 from the named filers, including signatures by Matthew Sesterhenn and William Blank, confirming the amendment's execution on that date.